Acoustic prosodic parameters associated with Parkinson's disease cognitive impairment
Ye Liu1, Xi-Xi Wang1, Xu-Jun Wang2
1Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China.
Parkinsonism & Related Disorders
|February 2, 2025
Summary
Acoustic analysis can detect cognitive impairment in Parkinson's disease (PD) patients. Speech patterns like rate and pauses help differentiate between normal cognition, mild cognitive impairment (PD-MCI), and dementia (PDD).
Area of Science:
- Neurology
- Speech-language pathology
- Biomedical acoustics
Background:
- Acoustic prosodic analysis shows promise for identifying mild cognitive impairment (MCI) and dementia in Alzheimer's disease (AD).
- The study hypothesizes that acoustic analysis can also differentiate cognitive impairment in Parkinson's disease (PD).
Purpose of the Study:
- To investigate the utility of acoustic parameters in differentiating cognitive impairment in Parkinson's disease (PD).
- To evaluate the importance and clinical implications of acoustic parameters for identifying PD with cognitive impairment.
Main Methods:
- Investigated acoustic parameters in 90 subjects: 30 PD with normal cognition (PD-NC), 30 PD with mild cognitive impairment (PD-MCI), and 30 PD with dementia (PDD).
- Utilized reading ('Supermarket Passage') and picture description ('Cookie Theft') tasks.
- Performed feature selection and modeling to assess acoustic parameters' role in identifying cognitive impairment.
Main Results:
- Acoustic parameters were independently associated with cognitive impairment (PDD and PD-MCI), with an AUC of 0.826 for detection.
- Speech rate, pre-verb pause (≥1s), and between-utterance pause (≥2s) in the 'Cookie Theft' task were key factors.
- Feature selection showed high AUC for discriminating PDD (0.944) and PD-MCI (0.753) from PD-NC.
Conclusions:
- Acoustic parameters effectively differentiate PD patients with cognitive impairment from those with normal cognition, independent of age.
- Acoustic parameters show potential for automated screening of cognitive decline risk in PD patients.
- Further investigation into acoustic analysis for PD cognitive assessment is warranted.
Related Concept Videos
Parkinson's Disease: Treatment
192
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
192
Parkinson's Disease: Overview
447
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
447
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K


